What did the research discover?
The U.S. Food and Drug Administration (FDA) has approved FluMist for self- or caregiver-administration. FluMist is a nasal spray vaccine that helps prevent the flu (influenza) in people aged 2 through 49.
While FluMist has been around since 2003, it previously had to be administered by a healthcare provider. Now, it can be given by either the person themselves or a caregiver, making it more convenient and accessible for families.
Flu is a highly contagious respiratory illness that affects millions of people in the U.S. every year, with the potential to cause serious health complications, especially in the elderly, young children, and people with chronic conditions.
Vaccination is the best way to protect yourself from the flu, and FluMist adds another option for staying safe.
FluMist contains a weakened form of the flu virus and is sprayed directly into the nose. While it still requires a prescription, this new approval allows it to be delivered to your home through an online pharmacy, after a screening process.
The most common side effects are mild, such as a runny nose, congestion, or a slight fever in younger children.
How can I apply this research?
FluMist is for people between the ages of 2 and 49. For those who prefer a needle-free flu vaccine option, FluMist may be a good choice for you.
With this new approval, you can now have it shipped to your home and administer it yourself or have a caregiver help. This can be particularly helpful if scheduling a doctor’s appointment is difficult or if you prefer the convenience of home care.
For families with young children, caregivers can administer the vaccine to those under 17. Adults can self-administer the vaccine.
Just remember, you’ll need to complete a screening process online before receiving the vaccine through a third-party pharmacy.
Each flu season can be different, and getting vaccinated is your best defense against this potentially serious illness.
If you or your family members are eligible for FluMist, consider discussing this option with your healthcare provider.
Source:
- U.S. Food and Drug Administration. FDA approves nasal spray influenza vaccine for self- or caregiver-administration [Internet]. 2023 Sep 27 [cited 2024 Oct 1]. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-nasal-spray-influenza-vaccine-self-or-caregiver-administration
- U.S. Food and Drug Administration. Product-Specific Guidances for Generic Drug Development. [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; [cited 2025 Jan 14]. Available from: https://www.fda.gov/media/180697/download?attachment
